BioMarin officer plans sale of 5,147 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BioMarin Pharmaceutical Inc. (BMRN) officer Gregory R. Friberg reported an intended sale of 5,147 common shares, with an approximate sale date of November 18, 2026, and an aggregate market value of $302,710.44. The shares were acquired from the issuer through restricted stock vesting on September 30, 2026. Fidelity Brokerage Services LLC is named as the broker.
Key Figures
Key Terms
Restricted Stock Vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.